Europe midday: Stocks inch lower as risk appetite fades, ECB in focus

European stock markets were in the red on Thursday as nervousness about stubborn inflation and uncertainty surrounding the interest-rate outlook dampened risk sentiment.

Deutsche Bank trading oit

Source: Sharecast

The pan-European Stoxx 600 index was down 0.24% at 505.39 by the midday mark CEST, with losses of between 0.1% and 0.5% being registered across London, France, Frankfurt, Milan and Madrid.

Global stock markets suffered a steep sell-off on Wednesday afternoon – though European indices had recovered somewhat by the close of play – after a stronger-than-expected acceleration in US inflation dashed any hopes that the Federal Reserve is close to cutting interest rates. This was the third straight month of the consumer price index coming in above forecasts.

"While this situation persists, rate cut expectations are being pushed further out into the year with September now pegged as the lift off point for easing," said analyst James Harte of TickMill Group.

"If inflation continues to hold around current levels, however, we could well see rates projections for the remainder of the year changing significantly with the Fed likely to alter its forecast from three rate cuts down to two or less."

Back in Europe, with no major economic data due for release, eyes were firmly fixed on the European Central Bank meeting, which concludes at 1415 CEST, though no change in policy is expected.

"Equity bulls will hope that the ECB can turn the tide on market sentiment today, with [ECB chief] Christine Lagarde expected to take on a notably more dovish tone that could set us up for a rate hike in June," said Joshua Mahony, chief market analyst at IG.

Market movers

French advertising and PR titan Publicis edged higher after reporting a 5.3% increase in revenues in its first quarter, ahead of expectations, on the back of new business wins.

Swiss fragrance group Givaudan also impressed with a 13% jump in first-quarter like-for-like sales, ahead of the 6.9% growth expected by consensus.

UK-listed biopharma giant AstraZeneca announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Elsewhere in London, broker comments were moving stocks: Marks & Spencer gained at JPMorgan Cazenove upgraded the retailer to ‘overweight’ from ‘neutral’; while asset managers Jupiter and Liontrust were hit by downgrades from Barclays, to 'underweight' and 'equal weight', respectively.

Meanwhile, UK-listed self-storage firm Lok'nStore surged 17% after agreeing to be bought by Belgian rival Shurgard in a £378m deal.

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.